HUL 4Q FY 2013

Embed Size (px)

Citation preview

  • 7/30/2019 HUL 4Q FY 2013

    1/12

    Please refer to important disclosures at the end of this report 1

    Quarterly results (standalone)

    (` cr) 4QFY2013 4QFY2012 % yoy Angel Est. % DiffRevenue 6,367 5,660 12.5 6,354 0.2EBITDA 873 728 20 852 2.5

    OPM (%) 13.7 12.9 85 13.4 31

    Recurring PAT 778 659 18.1 854 (8.9)

    Source: Company, Angel Research

    HUL has delivered an encouraging set of numbers for 4QFY2013, with the 6%

    volume growth in the domestic consumer marking a reversal in the trend of

    decline in volume growth over the past few quarters. We remain Neutral on thestock.Key highlights during the quarter: The companys top-line and bottom-line roseby 12.5% and 18.1% respectively. The OPM stood at 13.7%, ahead of our

    estimates of 13.4%. HUL managed to revive volume growth (6% yoy in

    4QFY2013 vs 5% yoy in 3QFY2013) by passing on some benefits of reduction in

    raw material costs to customers by way of price cuts, and with increased

    advertising and promotion (A&P) expenditure bearing results. The Soaps and

    Detergents segment grew by 12.6% yoy. The high margin Personal Products

    segment rose by 12.1% yoy, while the Beverages segment grew 18.3% yoy.

    HULs promoter Unilever PLC has decided to make a voluntary open offer to buy

    a 22.52% stake, which would take its stake in HUL to 75%. The open offer has

    been priced at `600/share. As per Unilevers CEO Paul Polman, the US$5.4bn

    deal represents a further step in Unilevers strategy to invest in emerging markets

    and offers a liquidity opportunity at an attractive premium for existing

    shareholders. In our view, this move by Unilever indicates the huge confidence it

    has on the potential of Indias consumer sector.

    Outlook and valuation:We expect HUL to post an ~14.7% and 11.7% CAGR inits top-line and bottom-line respectively, over FY2013-15E. At the current marketprice, the stock is trading at 31.1x FY2015E earnings. We maintain our Neutral viewon the stock.Key financials (Standalone)

    Y/E March (` cr) FY2012 FY2013E FY2014E FY2015ENet sales 21,736 25,206 29,167 33,164% chg 12.0 16.0 15.7 13.7

    Net profit (Adj.) 2,573 3,188 3,695 3,978% chg 22.6 23.9 15.9 7.7

    OPM (%) 13.4 13.5 13.6 13.7

    EPS (`) 11.9 14.7 17.1 18.4P/E (x) 46.0 38.8 33.5 31.1

    P/BV (x) 35.2 46.3 32.2 23.3

    RoE (%) 83.4 103.1 113.4 87.0RoCE (%) 74.2 107.4 91.1 77.0

    EV/Sales (x) 5.5 4.8 4.1 3.6

    EV/EBITDA (x) 41.3 35.4 30.2 26.1

    Source: Company, Angel Research

    NEUTRALCMP `572

    Target Price -

    Investment Period -

    Stock Info

    Sector

    (3,563)

    Bloomberg Code HUVR@IN

    Shareholding Pattern (%)

    Promoters 52.5

    MF / Banks / Indian Fls 8.5

    FII / NRIs / OCBs 22.0

    Indian Public / Others 17.0

    Abs. (%) 3m 1yr 3yr

    Sensex (1.3) 14.0 12.4

    HUVR 19.8 37.5 139.5

    FMCG

    Market Cap (`cr) 123,769

    0.3

    52 Week High / Low 597/401

    BSE Sensex 19,736

    Nifty 5,999

    Net Debt (`cr)

    Reuters Code HLL.BO

    Avg. Daily Volume 216,380

    Face Value (`) 1

    Beta

    V Srinivasan022-39357800 Ext: 6831

    [email protected]

    HULPerformance Highlights

    4QFY2013 Result Update | FMCG

    May 2, 2013

  • 7/30/2019 HUL 4Q FY 2013

    2/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 2

    Exhibit 1:Quarterly performance (Standalone)Y/E March (` cr) 4QFY2013 4QFY2012 % chg yoy 3QFY2013 % chg qoq FY2013 FY2012 % chgNet Sales 6,367 5,660 12.5 6,434 (1.0) 25,206 21,736 16.0Consumption of RM 3,433 3,122 9.9 3,419 0.4 13,489 11,738 14.9(% of Sales) 53.9 55.2 53.1 53.5 54.0

    Staff Costs 312 275 13.5 343 (8.9) 1,318 1,107 19.1

    (% of Sales) 4.9 4.9 5.3 5.2 5.1

    Advertising Expenses 821 677 21.2 822 (0.1) 3,232 2,635 22.7

    (% of Sales) 12.9 12.0 12.8 12.8 12.1

    Other Expenses 928 858 8.2 982 (5.5) 3,767 3,345 12.6

    (% of Sales) 14.6 15.2 15.3 14.9 15.4

    Total Expenditure 5,494 4,933 11.4 5,566 (1.3) 21,806 18,825 15.8Operating Profit 873 728 19.9 868 0.6 3,400 2,911 16.8OPM 13.7 12.9 85 13.5 23 13.5 13.4 10

    Interest 6.0 0.2 2,905.0 7.5 (20.2) 25 1 1,928.2

    Depreciation 61 57 7.6 59 3.6 236 218 8.1

    Other Income 205 175 16.6 355 (42.4) 1,210 659 83.7

    PBT (excl. Extr Items) 1,010 846 19.4 1,156 (12.6) 4,349 3,350 29.8Extr Income/(Expense) 9 28 (7) 608 119

    PBT (incl. Extr Items) 1,020 874 16.6 1,148 (11.2) 4,958 3,469 42.9(% of Sales) 16.0 15.4 17.8 19.7 16.0

    Provision for Taxation 232 188 23.9 277 (16.1) 1,161 778 49.3

    (% of PBT) 23.0 22.2 24.0 26.7 23.2

    Recurring PAT 778 659 18.1 879 (11.5) 3,188 2,573 23.9Source: Company, Angel Research

    Revenue growth at 12.5% yoy

    HULs Home & Personal Care (HPC) and Foods businesses registered a double

    digit growth, resulting in an overall top-line growth of 12.5% yoy. Volume growth

    stood at 6%.

    The Soaps And Detergents segment posted a 13.0% yoy growth, with both

    laundry and skin cleansing segments reporting healthy growth rates. However,

    the growth of Personal Products segment continued to remain relatively weak at

    12% yoy due to the slowdown in discretionary spending. Beverages grew by 18%

    yoy, with tea delivering one of its strongest quarters. The Packaged Foods

    segment grew by 7% yoy.

  • 7/30/2019 HUL 4Q FY 2013

    3/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 3

    Exhibit 2:Top-line grows by 12.5% yoy

    Source: Company,Angel Research

    Exhibit 3:Volume growth revives marginally

    Source: Company, Angel Research

    OPM up by 85bp yoy to 13.7%; Net profit up by 18.1% yoyDuring the quarter, HUL reported a 125bp yoy improvement in gross margin

    aided by fall in prices of PFAD (a key raw material). The company increased its

    A&P expenses during the quarter by`144cr yoy to `821cr. A&P expenses as a

    proportion of sales stood at 12.9%, up 90bp on a yoy basis. The companys

    OPM rose by 85bp on a yoy basis. During the quarter, HUL posted an 18.1%

    yoy increase in its recurring net profit to `778cr (`659cr in 4QFY2012).

    Exhibit 4:Recurring PAT growth remains healthy

    Source: Company, Angel Research

    Exhibit 5: Gross margin grows but OPM remains flat

    Source: Company, Angel Research

    4,8

    94

    5,4

    96

    5,5

    22

    5,8

    44

    5,6

    60

    6,2

    50

    6,1

    55

    6,4

    34

    6,3

    67

    13.414.6

    18.0

    16.3 15.713.7

    11.510.1

    12.5

    -

    5.0

    10.0

    15.0

    20.0

    -

    1,000

    2,000

    3,000

    4,000

    5,000

    6,000

    7,000

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    Top-line (LHS) yoy growth (RHS)

    14

    8

    109

    109

    7

    56

    -

    2

    4

    6

    8

    10

    12

    14

    16

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    486

    568

    645

    766

    659

    727

    805

    879

    778

    25.9

    10.4

    22.6

    33.7

    35.6

    27.8

    25.0

    14.7

    18.1

    -

    5.0

    10.0

    15.0

    20.0

    25.0

    30.0

    35.0

    40.0

    10

    210

    410

    610

    810

    1,010

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    PAT (LHS) yoy growth (RHS)

    12.4 11.6 12.0 13.414.7 12.9 13.4 13.3 13.5 13.7

    48.945.6

    44.045.7 47.3

    44.846.1 46.9 46.9 46.1

    -

    10.0

    20.0

    30.0

    40.0

    50.0

    60.0

    3Q11

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    OPM Gross margin

  • 7/30/2019 HUL 4Q FY 2013

    4/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 4

    Exhibit 6:Segmental PerformanceY/E March (` cr) 4QFY2013 4QFY2012 % chg 3QFY2013 %chg FY2013 FY2012 % chgIncomeSoaps & Detergents 3,191 2,834 12.6 3,171 0.6 12,702 10,636 19.4Personal Products 1,831 1,633 12.1 2,049 (10.6) 7,472 6,585 13.5

    Beverages 808 683 18.3 793 1.9 2,875 2,617 9.8

    Packaged Foods 372 348 7.0 330 12.8 1,506 1,359 10.8

    Others 250 260 (3.7) 290 (13.8) 1,093 897 21.8

    Total Gross Income 6,453 5,759 12.1 6,633 (2.7) 25,647 22,095 16.1PBIT segment wise bifurcationSoaps & Detergents 383 320 19.7 394 (2.7) 1,616 1,233 31.0

    Personal Products 472 449 5.0 579 (18.5) 1,949 1,749 11.4

    Beverages 136 98 38.4 140 (3.0) 475 367 29.4

    Packaged Foods 14 (4) (477) (3) (631) 37 24 53.2

    Others (16) (5) 228.8 (19) (13.7) (39) (30)

    Total PBIT 989 859 15 1,092 (9) 4,037 3,344 20.7Less: Interest Exp (6) (0) (8) (25) (1)

    Less: Other Unallocable Exp 39 15 64 946 126

    PBT 1,022 874 16.9 1,148 (11.0) 4,958 3,469 42.9PBIT Margin (%)Soaps & Detergents 12.0 11.3 12.4 12.7 11.6

    Personal Products 25.8 27.5 28.3 26.1 26.6

    Beverages 16.9 14.4 17.7 16.5 14.0

    Packaged Foods 3.8 (1.1) (0.8) 2.5 1.8

    Others (6.4) (1.9) (6.4) (3.6) (3.3)

    Source: Company, Angel Research

    S&D posts double-digit growth, all brands perform well

    The Soaps & Detergents segment posted a healthy 12.6% and 19.7% yoy growth

    in sales and profit respectively with key brands in both the skin cleansing and

    laundry segments posting a double digit volume growth. Skin Cleansing sustained

    its broad based growth momentum led by brands such as Dove, Lux and

    Lifebuoy, which posted double digit volume growths. The company strengthened

    its body wash portfolio with the relaunch of Dove. The growth in the laundry

    segment was led by premium brands withSurfand Rin registering a double-digit

    volume growth.

  • 7/30/2019 HUL 4Q FY 2013

    5/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 5

    Exhibit 7:S&D continues to post impressive growth

    Source: Company, Angel Research

    Exhibit 8:EBIT margin up by 71bp yoy

    Source: Company, Angel Research

    Personal products posts weak growthThe growth of Personal Products remained weak at 12% yoy due to significant

    slowdown in market growth. Despite the slowdown, Ponds age miracle sustained

    its strong momentum. There was broad based growth in the oral portfolio as well,

    with both Close Up and Pepsodent posting double digit volume growth.

    Exhibit 9:Personal products growth subdued at 12%

    Source: Company, Angel Research

    Exhibit 10:Segments EBIT margin expands

    Source: Company, Angel Research

    Foods division grows by 14.5% yoyIn the foods category, while growth in the Beverages segment was strong at 18.3%

    yoy, the Packaged Foods grew by a moderate 7% yoy. In the Beverages segment,

    growth was strong in both - tea and coffee. In the Packaged Foods segment

    growth was led by Kissan and Knorr while Kwality Walls registered a modest

    growth.

    2,2

    05

    2,5

    58

    2,5

    96

    2,6

    48

    2,8

    34

    3,1

    63

    3,1

    76

    3,1

    71

    3,1

    91

    11.412.9

    21.9

    20.8

    28.6

    23.722.3

    19.8

    12.6

    -

    5.0

    10.0

    15.0

    20.0

    25.0

    30.0

    -

    500

    1,000

    1,500

    2,000

    2,500

    3,000

    3,500

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    Top-line (LHS) yoy growth (RHS)

    166

    236

    321

    356

    320

    385

    454

    394

    383

    7.5

    9.2

    12.413.4

    11.312.2

    14.3

    12.4 12.0

    -

    2.0

    4.0

    6.0

    8.0

    10.0

    12.0

    14.0

    16.0

    -

    100

    200

    300

    400

    500

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    EBIT (LHS) EBIT % (RHS)

    1,4

    59

    1,6

    33

    1,5

    56

    1,8

    13

    1,6

    33

    1,8

    47

    1,7

    45

    2,0

    49

    1,8

    31

    16.2

    19.6

    14.0

    9.6

    11.9 13.1 12.1 13.0 12.1

    -

    5.0

    10.0

    15.0

    20.0

    25.0

    -

    500

    1,000

    1,500

    2,000

    2,500

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    Top-line (LHS) yoy growth (RHS)

    365

    413

    394

    488

    456

    477

    423

    579

    472

    25.025.3 25.3

    26.9

    27.9

    25.8

    24.2

    28.3

    25.8

    22.0

    23.0

    24.0

    25.0

    26.0

    27.0

    28.0

    29.0

    -

    100

    200

    300

    400

    500

    600

    700

    4Q11

    1Q12

    2Q12

    3Q12

    4Q12

    1Q13

    2Q13

    3Q13

    4Q13

    (%)

    (`cr)

    EBIT (LHS) EBIT % (RHS)

  • 7/30/2019 HUL 4Q FY 2013

    6/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 6

    Unilever makes a voluntary open offer to increase stake in HUL

    HULs promoter Unilever PLC has decided to make a voluntary open offer to buy

    22.52% stake in the company at an offer price of `600/share. Unilever currently

    holds 52.5% stake in HUL and proposes to take its total stake in the company to

    75%, which is the maximum permissible promoter holding limit in a listed

    company. As per Unilevers CEO Paul Polman, the US$5.4bn deal represents a

    further step in Unilevers strategy to invest in emerging markets and offers a

    liquidity opportunity at an attractive premium for existing shareholders. Currently,

    more than 50% of Unilevers total turnover comes from emerging markets such as

    India, Brazil, Indonesia, Turkey, South Africa, China etc. India contributes ~7% of

    Unilevers total turnover. In our view, this move by Unilever indicates the huge

    confidence it has over the potential of Indias consumer sector

    Investment arguments

    Increasing innovation and brand repositioning to accelerate growth: HUL hasbeen very actively re-launching products from its existing brands and has

    increased the pace of new launches, targeting the mid/premium market

    segment. This, in our view, is positive, considering that the company will have

    a better control on pricing. Moreover, constant innovations have helped HUL

    stabilize its market share losses.

    Healthy domestic growth rates and strong balance sheet provide furtherimpetus: HUL, with its iconic brands, has maintained its growth which isimpressive given the recent price hikes across categories and a strongcompetitive scenario, indicating a revival in consumer demand and highergrowth in the mid/premium market segment. Moreover, HUL is a

    cash-rich, zero-debt company enjoying a high RoE .

    Outlook and valuation

    We expect HUL to post an ~14.7% and 11.7% CAGR in its top-line and

    bottom-line respectively over FY2013-15E. At the current market price, the stock istrading at 31.1x FY2015E earnings. We maintain our Neutral view on the stock.

  • 7/30/2019 HUL 4Q FY 2013

    7/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 7

    Exhibit 11: Peer valuationCompany Reco Market CMP TP Upside P/E (x) EV/Sales (x) RoE (%) CAGR#

    Cap ` ` (%) FY14E FY15E FY14E FY15E FY14E FY15E Sales PATAsian Paints Neutral 45,337 4,727 - - 32.9 27.8 3.3 2.7 35.0 32.7 18.8 18.0

    Britannia Neutral 6,874 576 - - 28.4 22.9 1.0 0.8 37.4 37.3 15.5 22.0

    Colgate Neutral 20,466 1,505 - - 33.6 29.0 5.5 4.7 98.3 88.0 15.1 17.4

    Dabur India Neutral 26,210 151 - - 27.8 23.8 3.6 3.0 43.9 39.9 16.0 19.7

    Godrej Con Neutral 28,580 840 - - 31.7 26.3 3.8 3.1 26.5 25.9 18.8 22.2

    GSK Con Neutral 17,557 4,175 - - 34.6 28.5 4.5 3.5 33.7 33.4 17.6 18.7

    HUL* Neutral 123,771 572 - - 33.5 31.1 4.1 3.5 113.4 87.0 14.7 11.7ITC Neutral 260,705 333 - - 30.1 25.7 7.4 6.0 35.5 34.1 15.3 16.6

    Marico Neutral 14,222 221 - - 27.9 22.5 2.6 2.1 22.8 22.9 14.8 23.3

    Nestle Neutral 47,465 4,923 - - 37.4 30.8 4.7 4.0 58.8 69.5 16.7 18.4

    TGBL Neutral 9,202 149 - - 18.9 17.1 1.1 0.5 9.5 9.8 10.0 13.0

    Source: Angel Research; # CAGR over FY2013-15E

    Exhibit 12:Angel vs Consensus estimatesTop-line (` cr) FY2014E FY2015E EPS (`) FY2014E FY2015EAngel estimates 29,167 33,164 Angel estimates 17.1 18.4

    Consensus 29,158 32,959 Consensus 16.9 18.3

    Diff (%) 0.0 0.6 Diff (%) 1.3 0.6

    Source: Bloomberg, Angel Research

    Exhibit 13:One-year forward P/E chart

    Source: Company, Angel Research

    Exhibit 14:One-year forward premium to Sensex

    Source: Company, Angel Research, Note: Blue line indicates 5-year average

    Company Background

    HUL, a 52% subsidiary of Unilever, is one of India's largest consumer goods

    companies. HUL is present across four main product categories 1) Soaps And

    Detergents (50% of revenue); 2) Personal Products (mainly shampoos, skin care

    and toothpaste; 30% of revenue); 3) Beverages (mainly tea and coffee; 12% of

    revenue); 4) Packaged Foods and ice cream (6% of revenue); and 5) Others,

    mainly consisting of water purifiers. The company, with its iconic brands such as

    Lux, Lifebuoy, Surf Excel, Rin, Wheel, Fair & Lovely, Pond's, Vaseline, Lakm, Dove,

    Clinic Plus, Sunsilk, Pepsodent, Closeup, Axe, Brooke Bond, Bru, Knorr, Kissan andWalls, has a vast presence in rural as well as urban Indian markets, with one of the

    largest distribution networks spanning over 6.3mn retail outlets.

    -

    100

    200

    300

    400

    500

    600

    700800

    Jan-0

    6

    Jul-06

    Jan-0

    7

    Jul-07

    Jan-0

    8

    Jul-08

    Jan-0

    9

    Jul-09

    Jan-1

    0

    Jul-10

    Jan-1

    1

    Jul-11

    Jan-1

    2

    Jul-12

    Jan-1

    3

    SharePrice(`)

    20x 25x 30x 35x

    -40%

    -20%

    0%

    20%

    40%

    60%

    80%

    100%

    120%

    140%160%

    May-0

    7

    Sep-0

    7

    Jan-0

    8

    May-0

    8

    Sep-0

    8

    Jan-0

    9

    May-0

    9

    Sep-0

    9

    Jan-1

    0

    May-1

    0

    Sep-1

    0

    Jan-1

    1

    May-1

    1

    Sep-1

    1

    Jan-1

    2

    May-1

    2

    Sep-1

    2

    Jan-1

    3

  • 7/30/2019 HUL 4Q FY 2013

    8/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 8

    Profit & Loss Statement (Standalone)

    Y/E March (` cr) FY2010 FY2011 FY2012 FY2013 FY2014E FY2015ENet Sales 17,524 19,401 21,736 25,206 29,167 33,164

    Total operating income 17,524 19,401 21,736 25,206 29,167 33,164% chg (13.4) 10.7 12.0 16.0 15.7 13.7

    Total Expenditure 14,975 17,036 18,825 21,806 25,195 28,613

    Cost of Materials 8,878 10,057 11,738 13,489 15,517 17,643

    Advertising Exp 2,391 2,764 2,635 3,232 3,733 4,212

    Personnel 936 961 1,107 1,318 1,473 1,675

    Others 2,770 3,254 3,345 3,767 4,471 5,084

    EBITDA 2,548 2,365 2,911 3,400 3,973 4,550% chg (4.1) (7.2) 23.1 16.8 16.8 14.5

    (% of Net Sales) 14.5 12.2 13.4 13.5 13.6 13.7

    Depreciation& Amortisation 184 221 218 236 228 259

    EBIT 2,364 2,144 2,692 3,164 3,745 4,291% chg (3.9) (9.3) 25.6 17.5 18.4 14.6

    (% of Net Sales) 13.5 11.1 12.4 12.6 12.8 12.9

    Interest & other Charges 7 0 1 25 33 33

    Other Income 350 586 659 1,211 1,255 1,238

    (% of PBT) 12.9 21.5 19.7 27.8 25.3 22.5

    Share in profit of Associates - - - - - -

    Recurring PBT 2,707 2,730 3,350 4,349 4,967 5,496% chg (10.5) 0.9 22.7 29.8 14.2 10.6

    Prior Period & Extr. Exp./(Inc.) (99) (207) (119) (608) - -

    PBT (reported) 2,806 2,937 3,469 4,957 4,967 5,496Tax 604 631 778 1,161 1,272 1,517

    (% of PBT) 22.3 23.1 23.2 26.7 25.6 27.6

    PAT (Adjusted) 2,103 2,099 2,573 3,188 3,695 3,978Add: Share of earnings of asso. - - - - - -

    Recurring PAT 2,103 2,099 2,573 3,188 3,695 3,978Reported PAT 2,202 2,306 2,691 3,796 3,695 3,978% chg (11.8) 4.7 16.7 41.0 (2.7) 7.7

    (% of Net Sales) 12.6 11.9 12.4 15.1 12.7 12.0

    Basic EPS (`) 9.6 9.7 11.9 14.7 17.1 18.4Fully Diluted EPS (`) 9.6 9.7 11.9 14.7 17.1 18.4% chg (16.0) 0.9 22.4 23.9 15.9 7.7

  • 7/30/2019 HUL 4Q FY 2013

    9/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 9

    Balance Sheet (Standalone)

    Y/E March (` cr) FY2010 FY2011 FY2012 FY2013E FY2014E FY2015ESOURCES OF FUNDSEquity Share Capital 218 216 216 216 216 216Preference Capital - - - - - -

    Reserves& Surplus 2,365 2,444 3,297 2,458 3,626 5,092

    Shareholders Funds 2,584 2,660 3,513 2,674 3,843 5,308Total Loans - - - - - -

    Deferred Tax Liability (249) (210) (214) (205) (210) (210)

    Long term provisions 664 667 700 700 700

    Other long term liabilities 219 330 476 476 476

    Total Liabilities 2,335 3,333 4,295 3,645 4,809 6,275APPLICATION OF FUNDSGross Block 3,582 3,760 3,812 4,012 4,137 4,704

    Less: Acc. Depreciation 1,420 1,591 1,664 1,900 2,128 2,386

    Net Block 2,162 2,169 2,147 2,112 2,009 2,318Capital Work-in-Progress 274 289 215 397 414 470

    Goodwill - - - - - -

    Investments 1,264 1,261 2,438 2,331 3,031 4,031Long term loans and adv. 400 396 420 450 450

    Current Assets 5,368 5,834 5,547 6,048 6,703 7,515

    Cash 1,892 1,628 1,830 1,708 1,507 1,545

    Loans & Advances 624 452 521 980 717 877

    Other 2,852 3,754 3,196 3,360 4,479 5,093

    Current liabilities 6,733 6,620 6,449 7,662 7,797 8,508

    Net Current Assets (1,365) (786) (902) (1,614) (1,095) (994)Total Assets 2,335 3,333 4,295 3,645 4,809 6,275

  • 7/30/2019 HUL 4Q FY 2013

    10/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 10

    Cash Flow Statement (Standalone)

    Y/E March (` cr) FY2010 FY2011 FY2012 FY2013E FY2014E FY2015EProfit before tax 2,707 2,730 3,350 4,349 4,967 5,496

    Depreciation 184 221 218 236 228 259Change in Working Capital 1,375 (538) 205 361 (718) (124)

    Interest / Dividend (Net) (117) (190) (161) (154) (198) (47)

    Direct taxes paid 604 631 778 1,161 1,272 1,517

    Others (67) (142) 208 1,016 (50) 61

    Cash Flow from Operations 3,477 1,450 3,043 4,647 2,956 4,127(Inc.)/ Dec. in Fixed Assets (502) (192) 21 (382) (142) (624)

    (Inc.)/ Dec. in Investments (931) 3 (1,178) 108 (700) (1,000)

    Cash Flow from Investing (1,434) (189) (1,156) (274) (842) (1,624)Issue of Equity 32 (73) 38.1 0.1 - -

    Inc./(Dec.) in loans (422) - - - - -

    Dividend Paid (Incl. Tax) 1,656 1,642 1,884 4,649 2,513 2,513

    Interest / Dividend (Net) (117) (190) (161) (154) (198) (47)

    Cash Flow from Financing (1,929) (1,525) (1,685) (4,494) (2,315) (2,466)Inc./(Dec.) in Cash 115 (264) 201 (122) (201) 38

    Opening Cash balances 1,777 1,892 1,628 1,830 1,708 1,507Closing Cash balances 1,892 1,628 1,830 1,708 1,507 1,545

  • 7/30/2019 HUL 4Q FY 2013

    11/12

    HUL | 4QFY2013 Result Update

    May 2, 2013 11

    Key Ratios

    Y/E March FY2010 FY2011 FY2012 FY2013E FY2014E FY2015EValuation Ratio (x)P/E (on FDEPS) 56.7 53.6 46.0 38.8 33.5 31.1P/CEPS 54.1 53.3 44.3 36.1 31.5 29.2

    P/BV 47.9 46.5 35.2 46.3 32.2 23.3

    Dividend yield (%) 1.1 1.1 1.3 3.2 1.7 1.7

    EV/Sales 6.9 6.3 5.5 4.8 4.1 3.6

    EV/EBITDA 47.8 51.4 41.3 35.4 30.2 26.1

    EV / Total Assets 52.1 45.6 33.1 40.9 29.2 21.3

    Per Share Data (`)EPS (Basic) 9.6 9.7 11.9 14.7 17.1 18.4

    EPS (fully diluted) 9.7 9.7 11.9 14.7 17.1 18.4

    Cash EPS 10.6 10.7 12.9 15.8 18.1 19.6

    DPS 6.5 6.5 7.5 18.5 10.0 10.0

    Book Value 12.0 12.3 16.3 12.4 17.8 24.6

    Returns (%)ROCE (Pre-tax) 103.6 85.7 85.5 96.3 106.2 88.6

    Angel ROIC (Pre-tax) - - - - - -

    ROE 90.5 80.1 83.4 103.1 113.4 87.0

    Turnover ratios (x)Asset Turnover (Gross Block) 4.9 5.2 5.7 6.3 7.1 7.1

    Inventory / Sales (days) 45 53 42 46 46 46

    Receivables (days) 14 18 11 9 10 10

    Payables (days) 110 105 87 84 78 76

    WC cycle (ex-cash) (days) (68) (50) (50) (52) (36) (31)

  • 7/30/2019 HUL 4Q FY 2013

    12/12

    HUL | 4QFY2013 Result Update

    May 2 2013 12

    Source: Company, Angel Research

    Research Team Tel: 022 - 39357800 E-mail: [email protected] Website: www.angelbroking.com

    DISCLAIMERThis document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment

    decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make

    such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies

    referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and

    risks of such an investment.

    Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make

    investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this

    document are those of the analyst, and the company may or may not subscribe to all the views expressed within.

    Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and

    trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's

    fundamentals.

    The information in this document has been printed on the basis of publicly available information, internal data and other reliablesources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as thisdocument is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any wayresponsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report .Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify,nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. WhileAngel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory,compliance, or other reasons that prevent us from doing so.

    This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,

    redistributed or passed on, directly or indirectly.

    Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or

    other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in

    the past.

    Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in

    connection with the use of this information.

    Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to thelatest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may haveinvestment positions in the stocks recommended in this report.

    Disclosure of Interest Statement HUL

    1. Analyst ownership of the stock No

    2. Angel and its Group companies ownership of the stock No

    3. Angel and its Group companies' Directors ownership of the stock No

    4. Broking relationship with company covered No

    Ratings (Returns): Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%)Reduce (-5% to -15%) Sell (< -15%)

    Note: We have not considered any Exposure below `1 lakh for Angel, its Group companies and Directors